Owen Ang

Owen Ang

Auto-generated profile, based on publicly available information

Owen Ang

Immunology Translational Research Programme, Yong Loo Lin School of Medicine Department of Microbiology and Immunology, National University of Singapore, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2024 in Nature
Verified
Journal Article
Open access
PDF file
MTMinoru Takaoka
Minoru Takaoka
XZXiaohui Zhao
Xiaohui Zhao
HLHwee Ying Lim
Hwee Ying Lim
CMCostan G. Magnussen
Costan G. Magnussen
OAOwen Ang
Owen Ang
ZMZiad Mallat
Ziad Mallat
Hyperlipidaemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Risk of cardiovascular events depends on cumulative lifetime exposure to low-density lipoprotein cholesterol (LDL-C) and, independently, on the time course of exposure to LDL-C, with early exposure being associated with a higher risk1. Furthermore, LDL-C fluctuations are associated with ASCVD outcomes2–4. However, the precise mechanisms behind this increased ASCVD risk are not understood. Here we find that early intermittent feeding of mice on a high-cholesterol Western-type diet (WD) accelerates atherosclerosis compared with late continuous exposure to the WD, despite similar cumulative circulating LDL-C levels. We find that early intermittent hyperlipidaemia alters the number and homeostatic phenotype of resident-like arterial macrophages. Macrophage genes with altered expression are enriched for genes linked to human ASCVD in genome-wide association studies. We show that LYVE1+ resident macrophages are atheroprotective, and identify biological pathways related to actin filament organization, of which alteration accelerates atherosclerosis. Using the Young Finns Study, we show that exposure to cholesterol early in life is significantly associated with the incidence and size of carotid atherosclerotic plaques in mid-adulthood. In summary, our results identify early intermittent exposure to cholesterol as a strong determinant of accelerated atherosclerosis, highlighting the importance of optimal control of hyperlipidaemia early in life, and providing insights into the underlying biological mechanisms. This knowledge will be essential to designing effective therapeutic strategies to combat ASCVD.

11 February 2026 in Nature
Verified
Journal Article
Closed access
PDF file
HLHwee Ying Lim
Hwee Ying Lim
YZYuning Zhang
Yuning Zhang
SASyaza Hazwany Mohammad Azhar
Syaza Hazwany Mohammad Azhar
CTChung Hwee Thiam
Chung Hwee Thiam
MTMichaela Taylor
Michaela Taylor
VAVeronique Angeli
Veronique Angeli


8 February 2024 in Research Square
Verified
Preprint
Open access
PDF file
VAVeronique Angeli
Veronique Angeli
HLHwee Ying Lim
Hwee Ying Lim
SASyaza Hazwany Mohammad Azhar
Syaza Hazwany Mohammad Azhar
MYMohamed Ameen Shah Bin Mohamed Yunos
Mohamed Ameen Shah Bin Mohamed Yunos
YZYuning Zhang
Yuning Zhang
BTBien Keem Tan
Bien Keem Tan
Lymphedema is a chronic debilitating disease caused by impaired lymphatic drainage and is characterized by tissue swelling, fat expansion, inflammation, and fibrosis1,2. However, the exact mechanisms driving lymphedema are poorly understood. Lymphatic vessels are known to transport lipids including cholesterol from peripheral tissues back to the blood circulation3 but the impact of impaired lymphatic drainage on cholesterol clearance in humans and its potential effects on tissue homeostasis are still unknown. Here, we show that lymphatic drainage insufficiency in human lymphedema leads to excessive cholesterol accumulation in subcutaneous tissue. Cholesterol deposition resulted in adipose tissue remodeling, progressing from adipocyte hypertrophy and dysfunction to death and tissue fibrosis. Surgical therapy, on the other hand reversed the process through improved lymphatic drainage, ultimately resulting in reduced cholesterol deposition. We established a mouse model that better reproduces the features of human lymphedema and demonstrated that tissue swelling, adipocyte hypertrophy and fibrosis were reversed by cholesterol depleting agents including high-density lipoprotein and cyclodextrin (CD) that improved lymphatic drainage upon increasing cholesterol clearance and/or solubility. Ex vivo, CD also efficiently removed cholesterol from human lymphedematous skin biopsy samples. Our study unravels the central role of impaired cholesterol clearance in driving lymphedema progression by promoting adipose tissue remodeling and identifies tissue cholesterol as a promising therapeutic target for this disease which is incurable. Our work highlights the importance of optimal lymphatic drainage to protect against excess cholesterol and its harmful effects. This concept is known in atherosclerosis and may apply to other human diseases including neurological disorders, liver, and metabolic diseases.